The aim of this study was to investigate the associations between body mass index (BMI) in early and midadulthood, and BMI change between these ages, and mortality. 2 ) in mid-adulthood. All-cause mortality was associated with being overweight (BMIZ25 kg/m 2 ) at age 22 but not at age 38, adjusted hazard ratio (HR): 1.85 (95% confidence interval (CI) 1.09-3.13) and 1.05 (95% CI: 0.73-1.52), respectively. BMI at age 22 y was more strongly associated with CVD mortality than was BMI at age 38 y, adjusted HR 22 y : 2.41 (95% CI: 1.26-4.60) and HR 38 y : 1.33 (95% CI: 0.82-2.16). There was no clear relationship between cancer mortality and BMI at either age: HR 22 y : 0.68 (95% CI: 0.16-2.91), HR 38 y : 0.90 (95% CI: 0.44-1.84), although relatively few men died of cancer in the follow-up period. Similar patterns were seen for obesity (BMIZ30 kg/m 2 ) as for being overweight. Analyses of weight patterns indicated particularly detrimental effects of overweight persisting from early to mid-adulthood. CONCLUSIONS: BMI in early adulthood is positively related to CVD mortality in later life in men. The risk associated with early adulthood adiposity appeared to be greater than that in mid-adulthood. We did not demonstrate an association between weight gain and later mortality. These results reinforce the need to stem the obesity epidemic in children and young adults.
Introduction
Numerous studies have documented the greater mortality rates associated with higher body mass index (BMI) in adulthood. There is also accumulating evidence pointing to the detrimental effects of high BMI in childhood and early adulthood on adult disease. [1] [2] [3] As yet, it is unknown whether there is a critical age at which having a high BMI is particularly harmful.
There are methodological problems with studying BMI and BMI change in relation to later outcomes. Firstly, weight tends to track over the life course, so children and young adults who are overweight are more likely to remain overweight throughout their life. For example, in a Norwegian study, correlation coefficients between BMI at age 20-24 y and BMI approximately 16 y later were 0.80 in men and 0.73 in women. 4 These results suggest that inferences regarding the presence of a critical age at which being overweight is particularly deleterious are impossible from studies that use a single measure of BMI. Secondly, it is important to assess both baseline BMI and BMI change in relation to later outcomes. Each of these may be independently related to later disease. Weight gain during adult life is related to an increased risk of coronary heart disease (CHD) 5 and stroke 6 as well as breast 7 and prostate cancer. 8 Furthermore, since weight loss may be indicative of premorbid disease, it is important to either use measures of BMI from many years prior to the development of outcomes, or to exclude individuals from analyses who develop the outcome within the first few years of follow-up. 9 In this paper, we report the relative magnitude of the association between BMI in early and mid-adulthood, and BMI change, and mortality risk. With two measures of BMI and BMI change, as well as a long follow-up period, this study overcomes the problem of reverse causality mentioned above and may assist in pointing towards the presence of a critical period in relation to the association between BMI and mortality.
Methods
The study is based on a subset of the Glasgow Alumni Cohort, which has been described in detail elsewhere. 10 Briefly, students who were registered at the University of Glasgow at some time between 1948 and 1968 were invited to an annual medical examination at the Student Health Service. Approximately half the invited students attended. 10 We have traced approximately 82% of participants through the National Health Service Central Register (NHSCR). The copies of death certificates for these individuals are sent to us on a regular basis.
The current analysis is based on male students who attended the Student Health Service between 1948 and 1949 inclusive, and who responded to a postal survey sent in [1963] [1964] [1965] [1966] . At the Student Health Service, heights and weights were measured by a physician in Imperial units. These were converted to metric measures at the time of analysis. Few details of the postal survey remain, but it is thought participants were asked to measure their weight in full clothing and to report what they were wearing at the time of measurement. These measures, recorded on index cards, have been preserved. From the data recorded on these cards, it appears that, at the time of the survey, standard weights were assigned to each item of clothing and subtracted from the participant's reported weight. All measurements were recorded in Imperial units and later converted to metric units using the following conversions: 1 lb ¼ 0.455 kg and 1 in ¼ 2.54 cm.
We calculated early adult BMI in kg/m 2 using the weight and height measured at the Student Health Service. BMI in mid-adulthood was calculated using the reported weight from the postal survey and the student height measure. Cause of death was ascertained from the death certificate using the underlying cause of death. Primary outcomes studied were all-cause mortality and cardiovascular (CVD) mortality (ICD-9 390 to 459). Results for cancer mortality (ICD-9 140 to 209) are also presented, and we further stratified cancer mortality according to whether the aetiology of the cancer is thought to be related to smoking or not. 11, 12 The Cox proportional hazard models were used to estimate mortality risks. To characterise the mortality risk associated with patterns of overweight from early to mid-adulthood, three categories of weight change were identified. These were (i) normal weight at both ages, (ii) normal weight in early adulthood but overweight in mid-adulthood and (iii) overweight at both the ages. Mortality risk was estimated in each category, using the normal weight at both ages category as the baseline.
Results
From 1948 to 1949, 2953 male students attended the Student Health Service, of whom 695 responded to the postal questionnaire in the 1960s. This fraction is not a true response rate, since no information on the number of people who were contacted is available. The response rate is thought to have been approximately 75%. 13 There were no differences in mean age or mean BMI at university between the 2258 men who did not and the 695 men who did respond to the postal questionnaire (mean age: 22.83 vs 22.76 y, P ¼ 0.71; mean BMI 21.53 vs 21.55 kg/m 2 , P ¼ 0.79, respectively). We excluded participants with incomplete data on anthropometric measures or potential confounding variables (n ¼ 64) and those who had an NHSCR notification of emigration prior to the date of the postal survey (n ¼ 2). The results presented are based on the remaining 629 men.
The median age of these men when they attended the Student Health Service for the first time was The mean weight gain was 8.6 kg. There were 46 men who were overweight in young adulthood, of whom three were obese and 246 who were overweight in mid-adulthood, of whom 23 were obese. The participants were followed for a mean of 35.2 y (range 7-41 y) from the postal survey. During this time, 124 men (20%) died, of whom 68 died of CVD and 33 died of cancer. The mean age at death was 68.4 y. The mortality rate for cancer was 1.49 (95% confidence interval (CI) 1.06-2.10) and for CVD was 3.07 (95% CI: 2.42-3.90) per 1000 personyears. Crude HRs comparing overweight to normal weight individuals for all-cause mortality and CVD mortality are shown in Table 2 . The results show a strong positive association between being overweight at age 22 and allcause mortality; the crude HR comparing obese to normal weight men was 5.80 (95% CI: 1.43-23.59) at this age. There was no association between being overweight in mid-adulthood and all-cause mortality risk (see Table 2 ), but there was a positive relationship between being obese in mid-adulthood and all-cause mortality, 2.39 (95% CI: 1.26-4.57). Comparing the crude with the adjusted HRs, there was no evidence of confounding by height, social class in childhood, diastolic blood pressure or smoking status in young adulthood.
A strong positive association was observed between BMI in young adulthood and CVD mortality. The association between BMI in mid-adulthood and CVD mortality was much weaker. The same pattern was evident for relationships between obesity and CVD mortality, with higher, although less precise, risks associated with obesity in early adulthood (HR: 11.99, 95% CI: 2.91-49.45) than in later adulthood, HR: 3.72 (95% CI: 1.70-8.15).
There was a suggestion of an inverse relationship between BMI at both ages and cancer mortality, although the CIs are wide and are compatible with either an increased or a decreased risk in overweight individuals. Adjusted HR (95% CI) for the association between overweight in early adulthood and cancer mortality was 0.68 (0.16-2.91) and in midadulthood was 0.90 (0.44-1.84). These figures were based on 33 men who died of cancer, of whom two were overweight in young adulthood and 12 were overweight in mid-adulthood. Of the three men who were obese in young adulthood, none died of cancer. There was no relationship between obesity in later adulthood and cancer mortality (HR: 0.81, 95% CI: 0.11-6.01).
Seven men died of cancers related to smoking (respiratory tract, urinary tract and pancreas). The site of the cancer was not specified on the death certificate of four further men. The remaining 22 participants died of a cancer not thought to be related to smoking. None of those who died of a smoking-related cancer were overweight in young adulthood. Three of the seven individuals who died of a smokingrelated cancer were overweight in later adulthood, HR 1.18 (95% CI: 0.26-5.28). For cancers not thought to be related to smoking, the HRs comparing overweight to normal weight men were 0.49 (95% CI: 0.06-3.69) in early adulthood and 0.87 (0.37-2.09) in mid-adulthood.
The median change in BMI over the 16-y period was 2.7 kg/m 2 (IQR:
. Associations between BMI change and mortality are shown in Table 3 . These results indicate that there was no association between change in BMI from early to mid-adulthood and all-cause or CVD mortality. Adjustment for social class in childhood, smoking status in young adulthood, adult height and diastolic blood pressure in young adulthood did not affect these results. Similarly, there was no relationship between BMI change and BMI in early and mid-adulthood M Jeffreys et al cancer mortality (adjusted HR (95% CI) per 1 kg/m 2 change was 1.09 (0.94-1.27)). In examining the joint effects of BMI in young adulthood and BMI change from young to midadulthood on mortality, no effect of BMI change was found for any of the outcomes studied. The risks associated with each of the categories of patterns of overweight are shown in Table 4 . As only two men who were overweight at a young age subsequently became normal weight, these results are not presented. There was an indication of an adverse effect of being overweight in both young and mid-adulthood with respect to all-cause mortality. Men who were overweight at both ages had twofold risks of CVD mortality compared to men with stable normal weight. Adjusted results for cancer mortality showed no relationship between being normal weight than overweight compared to men who were of stable normal weight 0.95 (0.44-2.03), nor any relationship between men who were overweight at both ages compared to those who were normal weight at both ages 0.69 (0.16-3.01).
To investigate the possibility that morbidity-induced weight change preceding death could have explained some of our results, analyses were repeated excluding the six deaths that occurred in the first 10 y of follow-up, all of which occurred in years 8-10 following the postal survey. There was no difference in CVD mortality risk in men who were normal weight then became overweight compared to those who remained normal weight (HR: 1.12, CI: 0.64-1.98). There remained over two-fold risks in men who were 
Discussion
The results presented here indicate a positive association between BMI in early adulthood and all-cause mortality. Cause-specific analyses indicated that this relationship was primarily due to the increased risk of CVD mortality. Increases in BMI from early to mid-adulthood were unrelated to mortality in this cohort. Weight patterns indicated that men who were persistently overweight were at two-fold risk of CVD mortality compared to men who retained normal weight at both ages. There were no clear relationships between BMI at different ages and cancer mortality. For the early adult measures, we were able to use premorbid height and weight measured by a physician. Although we were unable to validate these, such measures are likely to be more accurate than self-reported or recalled weights. For example, in a study in the US in which girls were followed from menarche for approximately 33 y, there was substantial systematic bias evident in the recall of weight at the time of menarche.
14 This ranged from a 10% overestimation of weight by girls who were thinnest in adolescence to a 30% underestimation by those who were fattest. This inverse association between the degree of error and the original BMI percentile was approximately linear. Using contemporaneous weight measures eliminates this recall bias. For the calculation of BMI in mid-adulthood, we had to rely on self-reported weight at this age and the value of height measured 16 y previously. Despite this limitation, the contemporary self-reported weight measure is likely to be more accurate than a recalled measure, although the precision of self-reported weight is lower than when weight is measured. Error in the self-reported weight measure may account for the observation that the correlation coefficient between the two measures was lower than has been reported from a previous study. 4 Measures of potential confounders were taken at baseline and may have lacked precision. For example, because of the small numbers of smokers included in the study, the crude classification of smoking (yes vs no) may have resulted in residual confounding, although using smoking as a threelevel variable (nonsmoker, light smoker and moderate/heavy smoker) did not make any appreciable difference to the results. Furthermore, since data on smoking were collected only once (at baseline), some residual confounding may exist in the results for BMI in mid-adulthood, as patterns of smoking are likely to have changed over the course of the study and smoking cessation is commonly associated with weight gain. However, since statistical adjustment did not alter the results for early adulthood BMI, we believe that our results are unlikely to be strongly confounded by the accuracy or timing of measurement of these variables. There does, however, remain the problem of residual confounding by unmeasured variables. For example, exercise patterns in early and mid-adulthood are likely to have substantial effect on BMI at these time points and may also affect the outcomes studied.
A strength of the study is that there were no deaths in the 8 y following the second weight measure, providing reassurance that the associations that we see are not affected by morbidity-induced weight change preceding death. This issue of intentionality of weight change confounding the association between weight change and mortality is one that has impaired the interpretation of results from studies of weight change in older populations, where deaths have occurred soon after second or subsequent weight measures were made.
The main limitation of the study is one of statistical power. The small numbers of cohort members for whom we have self-reported weight in mid-adulthood may have impaired the ability to detect an association with the outcomes that we studied. This was a consequence of basing the results on the subset of the cohort with self-reported weight in mid-adulthood. Longer term follow-up of this subset will allow further cause-specific mortality to be studied. That overweight men were at higher risk of CVD mortality in this cohort was unsurprising. However, the differences in the strength of the associations that we observed between BMI at two time periods and CVD mortality in particular were striking. Comparing overweight to normal weight men, the risk of CVD mortality was over two-fold in young adulthood, and increased by only 20% in later adulthood. There are two possible explanations as to why this could have been observed. Firstly, the self-reported measure of weight in mid-adulthood is likely to have been less accurate than the value measured by a physician at the student health service. This random misclassification could have diluted the true association, indicating that the association could be similar at both ages. Secondly, it is possible that there is a critical period at which being overweight confers an increased risk of disease in later life. If this critical period was early adulthood, this could explain the observed results. There are few cohorts with measured height and weight and sufficient length of follow-up to investigate the joint role of BMI at different ages and later disease outcomes.
BMI change was unrelated to mortality in this cohort. Evidence to support the presence of an association between weight gain and CVD from previous epidemiological research is strong, which suggests that the second measure of weight in this cohort may be imprecise. This evidence comes from cohort studies which have, to varying extents, attempted to control for factors such as smoking, occult disease, comorbidity, and intent of weight loss. Cohort studies that have demonstrated this include a study from Sweden in which the lowest CHD mortality and myocardial infraction (MI) rates were seen in those men with stable weight from early to later adulthood. 5 In the Health Professionals' Study, weight gain since the age of 21 y was BMI in early and mid-adulthood M Jeffreys et al also positively associated with risk of CHD among men younger than 65 y. 15 The evidence that relates weight gain to cancer risk is less consistent than for CVD, and depends on the site of the cancer studied. Studies of prostate cancer are inconsistent 8, [16] [17] [18] and there is no evidence to suggest that weight gain is related to colorectal cancer. 3, 16, 19 Our results are consistent with those previously reported null findings, but need to be interpreted in light of the small number of men who died from cancer included in this study. The timing of the weight gain ought to be stated explicitly for useful comparisons to be made between studies. For example, Stoll suggested that weight gain at the time of menarche may be the most pertinent in terms of subsequent breast cancer risk. 20 Prospective cohort studies with repeated measures of weight throughout the life course, coupled with sophisticated analytical methods, will allow further exploration of the possible mortality risks associated with weight gain. Surprisingly, overweight men who lost weight in this study were at higher risk of CVD mortality in later life. This was not due to the presence of occult disease, since the association persisted having excluded those people who died in the first 10 years of follow-up. One possibility is that the weight loss in these men could partly be due to smoking, which would increase their risk of CVD in later life. However, we do not have data on smoking patterns in this data set to investigate this possibility.
There have been numerous suggestions regarding potential mechanisms that could link overweight and weight gain to disease risk. Firstly, the most usual cause of change in body weight is a result of fat accumulation. It has been proposed that excessive weight gain is therefore a better marker of adiposity in adult life, either in terms of quantity or distribution, than weight per se. 20 Fat deposition associated with age-related weight gain tends to occur centrally. 21 Abdominal obesity, as measured by waist circumference or waist-hip ratio, is a recognised risk factor for CVD and some cancers. [22] [23] [24] Secondly, BMI change is related to changes in hormonal profiles and metabolic changes in the body. Obesity is also related to lower levels of sex hormone binding globulin, 25 resulting in higher levels of bioavailable sex hormones. Furthermore, overweight is associated with hyperinsulinaemia, which in turn is related to increased bioactivity of insulin-like growth factor-I (IGF-I), as well as to its bioavailability through the association with IGF-binding proteins. 20, 26 Evidence is accumulating to suggest that growth patterns are related to cancer risk, possibly mediated through IGF-I levels. 27 In conclusion, we have shown that BMI in early-adulthood is more strongly associated with increased risk of all-cause and CVD mortality than BMI in mid-adulthood. We did not demonstrate an association between weight change from early to mid-adulthood and mortality. Men who were persistently overweight were at two-fold risk of CVD mortality compared to men who retained normal weight at both ages. The findings add to the evidence supporting the continued need to reduce BMI in early adulthood in order to reduce the burden of future chronic disease.
